Posted inNews and Updates
U.S. Healthcare Spending Trends: What You Need to Know
Explore the latest trends in U.S. healthcare spending, the impact of medical innovation, and the shift toward value-based care in this expert-led analysis.
Posted inNews and Updates
The Battle for Weight-Loss Pills: Smaller Players Rise Up
Smaller biotech firms are entering the weight-loss market with oral pills, challenging industry giants as they push for easier, scalable obesity treatment.
Posted inNews and Updates
TG Therapeutics Begins Phase 2 Trial for Schizophrenia
TG Therapeutics has launched a Phase 2 trial for BRIUMVI to treat resistant schizophrenia, exploring the role of B-cell depletion in psychiatric care.
Posted inNews and Updates
Hawaii Launches First Early-Phase Cancer Clinical Trial Unit
Hawaii opens its first early-phase cancer clinical trial center, giving patients local access to cutting-edge research and novel oncology therapies.
Posted inNews and Updates
New Parkinson’s Drug Trial Authorized by FDA
The FDA has authorized a new Parkinson’s disease clinical trial. Learn about this potential disease-modifying therapy and what it means for neuro research.
Posted inNews and Updates
Precision Psychiatry: Biomarker-Driven Depression Trial
Can biomarkers predict depression treatment success? Discover how a new precision medicine trial using bupropion and sertraline is changing psychiatry.
Posted inNews and Updates
New Clinical Trial Targets Improved Heart Failure Treatment
A new clinical trial explores innovative treatments for heart failure, aiming to improve patient outcomes and reshape standard cardiac care protocols.
Posted inNews and Updates
Selinexor Phase III SENTRY Trial Results: New Data Released
Explore the latest Phase III SENTRY trial results for selinexor. Discover how this XPO1 inhibitor is shaping the future of targeted oncology treatments.
Posted inNews and Updates
AI in Biologics: How CDMOs Are Transforming Drug Production
Discover how AI is revolutionizing biologics manufacturing, optimizing bioprocessing, and accelerating drug development timelines in modern CDMO workflows.
Posted inNews and Updates
EU Regulators Withdraw Recommendation for Tavneos
EU regulators have reversed their approval recommendation for Tavneos (avacopan). Discover what this setback means for the ANCA-associated vasculitis drug.